Results 21 to 30 of about 23,023 (232)

Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma [PDF]

, 2015
Author version made available in accordance with publisher policy.Abstract Background The poor prognosis and rising incidence of esophageal adenocarcinoma highlight the need for improved detection methods.
Bowen, Joanne M, Bright, Tim Flaxman, Chiam, Karen, Hussey, Damian James, Irivine, Tanya, Jones, Michael E, Keefe, Dorothy M K, Mayne, George C, Smith, Lorelle, Thompson, Sarah K, Wang, Tingting, Watson, David Ian, White, Imogen A   +12 more
core   +1 more source

Barrett's esophagus: Ten years of experience at a tertiary care hospital center in Mexico

Revista de Gastroenterología de México (English Edition), 2018
Introduction: The prevalence of Barrett's esophagus has been calculated at between 1.3 and 1.6%. There is little information with respect to this in Mexico.
F. Valdovinos-Andraca, A.R. Bernal-Méndez, R. Barreto-Zúñiga, D. Briseño-García, J.A. Martínez-Lozano, A.F. Romano-Munive, J. Elizondo-Rivera, F.I. Téllez-Ávila   +7 more
doaj   +1 more source

Gastroesophageal reflux disease and tooth erosion [PDF]

, 2011
The increasing prevalence of gastroesophageal reflux disease (GERD) in children and adults, and of “silent refluxers” in particular, increases the responsibility of dentists to be alert to this potentially severe condition when observing unexplained ...
Kaidonis, J., Ranjitkar, S., Smales, R.
core   +4 more sources

The Oxidative Damage and Inflammation Mechanisms in GERD-Induced Barrett’s Esophagus

Frontiers in Cell and Developmental Biology, 2022
Barrett’s esophagus is a major complication of gastro-esophageal reflux disease and an important precursor lesion for the development of Barrett’s metaplasia and esophageal adenocarcinoma.
Deqiang Han, Deqiang Han, Chao Zhang
doaj   +1 more source

DINAMIC SCREENING OF PRECANCEROUS ESOPHAGUS USING MOLECULAR GENETIC ANALYSIS

Сибирский онкологический журнал, 2020
Introduction. Esophageal adenocarcinoma develops from areas of intestinal metaplasia in Barrett’s esophagus, similar to how intestinal metaplasia transforms into gastric adenocarcinomas in the stomach.
V. V. Anishchenko, S. E. Titov, T. L. Poloz, Yu. A. Veryaskina, A. A. Arkhipova, I. V. Bubnov   +5 more
doaj   +1 more source

Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. [PDF]

PLoS ONE, 2008
Barrett's esophagus is a premalignant condition whereby the normal stratified squamous esophageal epithelium undergoes a transdifferentiation program resulting in a simple columnar epithelium reminiscent of the small intestine.
Douglas B Stairs, Hiroshi Nakagawa, Andres Klein-Szanto, Shukriyyah D Mitchell, Debra G Silberg, John W Tobias, John P Lynch, Anil K Rustgi   +7 more
doaj   +1 more source

Molecular biomarkers and ablative therapies for Barrett’s esophagus [PDF]

, 2012
Author version made available in accordance with the publisher's policy.Barrett’s esophagus is the major risk factor for esophageal adenocarcinoma. Endoscopic interventions which ablate Barrett’s esophagus mucosa lead to replacement with a new squamous ...
Chisolm, Jacob A, Hussey, Damian James, Mayne, George C, Watson, David Ian   +3 more
core   +1 more source

Additional file 1: of NSAID use and somatic exomic mutations in Barrettâ s esophagus

, 2018
Supplemental Methods: Additional file 1 describes details of the study subjects, study design, exposure quantification methods, sample processing and sequencing methodologies, statistical methods for all analyses, and copy number/cnLOH calling methods. (DOCX 88 kb)
Galipeau, Patricia, Oman, Kenji, Paulson, Thomas, Sanchez, Carissa, Zhang, Qing, Marty, Jerry, Delrow, Jeffrey, Kuhner, Mary, Vaughan, Thomas, Reid, Brian, Li, Xiaohong   +10 more
openaire   +1 more source

Single-cell analysis of Barrett's esophagus and carcinoma reveals cell types conferring risk via genetic predisposition. [PDF]

Cell Genom
Wenzel MC, Dasmeh P, Plum PS, Giel AS, Hoppe S, Franitza M, Jonas C, Thieme R, Zhao Y, Heider D, Palles C, Fitzgerald RC, Bruns CJ, Buettner R, Quaas A, Gockel I, Maj C, Chon SH, Schumacher J, Hillmer AM.   +19 more
europepmc   +3 more sources

Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies [PDF]

, 2005
Vascular endothelial growth factors ( VEGF)- A, - C and - D are members of the proangiogenic VEGF family of glycoproteins. VEGF-A is known to be the most important angiogenic factor under physiological and pathological conditions, while VEGF-C and VEGF-D
Ahn MJ, Baatar D, Banks RE, Berse B, Boucher Y, Coia LR, Dirix LY, Du JR, Gu ZP, Guo WZ, Hefler L, Hickey K, Hironaka S, Isaka N, Ishikawa M, Karpanen T, Kato H, Kitadai Y, Kitamura K, Koide N, Koukourakis MI, Kukk E, Kumar H, Lackey VL, Lewis CE, Li Z, Maniwa Y, Millikan KW, Mobius C, Nagata J, Nguyen M, Noguchi T, Nor JE, Ohtsu A, Roberts WG, Rockwell S, Roder JD, Salven P, Shih CH, Spence GM, Suit HD, Theunissen PH, Uchida S, Vogel SB, Wallner G, Weingartner K, Yamamoto Y, Yang B, Yeo KT   +48 more
core   +1 more source